METHODS: 507 patients from our outpatient nephrology and hypertension unit were included. For every patient at least one 24 hours ambulatory BP and pulse wave monitoring was available. We used Mobil-O-Graph (I.E.M., Stolberg, Germany) to perform the recordings and data analysis was performed with HMS Client Software. Demographic parameters and available data from clinical recordings were also included in the analysis. The development of eaPWV in relation to central systolic BP (cSBP) was assessed using scatter plot. Based on this analysis new characteristics of the eaPWV were generated: PWVslope and PWVbaseline. Using multipe regression approach the impact of demographic and clinical parameters on eaPWV, PWVbaseline and PWVslope was analysed. RESULTS: 48.7% of study collective was female. The mean age was 60.7 years and the mean body-mass index was 27.4 kg/m 2
. 92.5% have had established diagnosis of hypertension, 33.7% of hyperlipoproteinemia and 22.9% were smoker. 20.5% had diabetes mellitus and 29.6% eGFR <60 ml/min/1,73 qm. The mean brachial BP was 133/80 mmHg with the mean heart rate of 69.5 beats/min. The mean cSBP was 121.6613.4 mmHg and the mean eaPWV was 9.262.2 m/s. The mean PWVslope was 0.035 and the mean PWVbaseline was 4.9 m/s. eaPWV correlated with cSBP in a linear manner and can be expressed with following equation: eaPWV¼PWVslope*cSBPþPWVbaseline. Increased age, history of myocardial infarction and SBP were associated with increasing in eaPWV, while decreased diastolic BP (DBP) and eGFR were associated with increasing in eaPWV. DBP and age were significantly associated with PWVbaseline. No significant impact of any demographic or clinical parameter was observed for PWVslope. CONCLUSIONS: We observed the linear correlation between eaPWV and cSBP in every single recording in our study collective. As shown in previous studies higher age, impaired renal function, higher SBP and lower DBP were associated with higher eaPWV.Based on single 24 hours BP and PW monitoring we were able to calculate an individual PWVslope and PWVbaseline for every patient. Using these parameters a BPadjusted eaPWV (e.a. for SBP 120 mmHg) can be determined. The later can discriminate BP-associated change in PWV from the real vessel damage. Also, it makes this non-invasive parameter for the assessment of AS comparable along different recordings in the same subject or in different patients. The pathophysiology of MH is commonly extrapolated from the essential arterial hypertension and aging processes. Genetic causes are poorly understood, especially in young patients with renal impairment. Some authors even consider the renal disease per se as the very starting point of MH. METHODS: The objective of our study is to identify both clinical and prognosis data in patients under 40 years old at enrollment receiving a renal biopsy at their diagnosis of MH. RESULTS: From a retrospective and prospective collection carried out in 5 hospitals in Paris over 30 years , 57 patients have been included. They were men (N¼38) and women (N¼19) aged from 34 years on average; 31.5% were Caucasians and 26% were African Americans. The diagnosis of an "indeterminate vascular disease" (IVD) has been made in 60% of cases. The diagnosis of a primary glomerulopathy was finally adopted for 21% of the patients, among them 50% of Berger's disease. We did not obverse serious events associated with the renal biopsy procedure. In our selected population, only 3.5% of the patients had normal renal function, 31% required dialysis and 16% were eventually transplanted. Mortality was zero. After multivariate analysis, the only prognostic factor significantly associated with renal prognosis was creatininemia at the time of admission to the hospital (OR ¼ 1.009, 95% CI: [1,004-1,015], p <0.001). Interestingly, no significant pathologic or prognostic differences were found between Caucasians and African-Americans patients. CONCLUSIONS: IVD / nephroangiosclerosis has been found alone only in 60% of patients in this selected population. Despite the fact that we did not find any renal pathological features on the renal biopsy as a prognosis marker of the disease, our work suggests that a renal biopsy should be performed in any young patient with malignant hypertension. Indeed, the renal biopsy led to the discovery of a superimposed renal disease in more than 21% of all cases. In this small cohort, elevated creatininemia at the time of admission represents the only deleterious marker predictive of End Stage Renal Disease.
FO034 PATTERNS OF HYPERTENSION IN RENAL TRANSPLANT PATIENTS EVALUATED WITH 24H AMBULATORY BLOOD PRESSURE MONITORING

Miriana Dinic
INTRODUCTION AND AIMS: Hypertension (HTN) is particularly frequent in renal transplant recipients (RTR) and substantially contributes to the high cardiovascular risk of those patients. However, prevalence of the different patterns of hypertension in KTR using 24h ambulatory blood pressure monitoring (ABPM) along with their determining factor are lacking. The aim of our study was to describe the epidemiology of hypertension in RTR, based on ambulatory blood pressure monitoring (ABPM).
METHODS:
In this cross-sectional study, prevalent RTR were proposed systematic blood pressure work-up consisting of ABPM, office blood pressure (3 consecutive blood pressure measurements performed by a nurse after 5 minutes of quiet rest) and detection of orthostatic hypotension. Optimal target was defined as BP <130/80 mmHg, resistant HTN defined as BP above the target despite the use of at least 3 antihypertensive drugs including one diuretic. Orthostatic hypotension was defined as an orthostatic reduction in BP of at least 15 mmHg. RESULTS: Two hundred and eleven RTR (mean age of 61 years, 65% of male, 26% diabetic, 93% under CNI-based treatment, with post-transplant time ranging from 0.3 to 30 years) underwent ABPM. 89% of them were receiving antihypertensive treatment (2.2 different drugs on average including angiotensin renin blockers for 58% of the RTR). Mean ABPM was 132/76 mmHg not different from the mean office BP (131/72 mmHg). Proportion of RTR with optimal BP was 43% and 46% after ABPM and office BP evaluation, respectively (NS). Prevalence of resistant hypertension was around 20% irrespective of the BP measurement technique. White coat and masked hypertensions were present in 5% and 6% of RTR, respectively. Orthostatic hypotension was detected in 19% of the patients (asymptomatic in 2 thirds of them). In multivariate analysis, RTR age, albuminuria and CKD stages 3b and below were independent factors associated to uncontrolled/resistant hypertension. CONCLUSIONS: Our findings suggest that ABPM does not confer significant advantage over a well formalized office BP measurement in order to characterize BP profile of RTR. While prevalence of resistant hypertension seems to be lower than in the general and native CKD populations, our data suggest that orthostatic hypotension is frequent and needs to be systematically detected.
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